Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Morris Reichlin Contributes Five Decades of Immunologic Advances in Rheumatology

Gretchen Henkel  |  Issue: October 2012  |  October 1, 2012

Dr. Reichlin has published more than 331 papers, lectured worldwide, and received a plethora of awards. His body of work, including his demonstration of the pathogenic roles of autoantibodies in SLE (anti-Ro in skin lesions and anti-Ro from affected kidneys), garnered him the Evelyn V. Hess, MD, Research Award, presented in 2006 at the ACR annual meeting. He also received a prize for lifetime contributions to autoimmunity from the International Congresses of Autoimmunity. Looking back on his productive career, Dr. Reichlin says, “It was always exciting to come into new areas that had not been explored before, and find a direction that was fruitful and productive.” Dr. James notes that Dr. Reichlin often emphasized that “things don’t always go perfectly in the lab—or the clinic—and that part of the work is persistence and perseverance and trying to do what’s best for the patients.”

Because of his dedication to patient-oriented research, tens of thousands of patients are helped by his discoveries every year. With characteristic modesty, Dr. Reichlin adds, “Finding ways around brick walls is what research is all about. I just wanted to solve problems and see where it led me. And it’s worked out very well.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Gretchen Henkel is writing the “Profiles in Rheumatology” series.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Timeline

1959 – Earns MD from Washington University, St. Louis

1959 – Becomes intern at Bronx Municipal Hospital Center (Albert Einstein College of Medicine)

1960 – Becomes assistant resident at Bronx Municipal Hospital Center

1961 – Becomes research associate at Brandeis University

1963 – Begins postdoctoral fellowship at University of Rome

1964 – Becomes an instructor at University of Vermont College of Medicine

1965 – Becomes assistant professor of medicine at State University of New York at Buffalo School of Medicine

1968 – Becomes associate professor of medicine and biochemistry at State University of New York at Buffalo School of Medicine

1971 – Becomes professor of medicine and biochemistry at State University of New York at Buffalo School of Medicine

1974 – Completes a sabbatical at the Royal College of Surgeons in London

1981 – Becomes professor of medicine and chief of the immunology section at University of Oklahoma Health Sciences Center

1981 – Becomes head of the arthritis and immunology program at OMRF

References

  1. Clark, G, Reichlin, M, Tomasi, TB. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol. 1969. 102:117-122.
  2. Reichlin M, Hay M, Levine L. Immunochemical studies of hemoglobin and myoglobin and their globin moieties. Biochemistry. 1963;2:971 979.
  3. Reichlin M, Hay M, Levine L. Antibodies to human A1 hemoglobin and their reactions with A2, S, C and H hemoglobins. Immunochemistry. 1964;1:21 30.
  4. Reichlin M, Fogel S, Nisonoff A, Margoliash E. Antibodies against cytochromes c from vertebrates. J Biol Chem. 1966;241:251 253.
  5. Reichlin M. Use of antibody in the study of protein structure in protein sequence determination. In: Needleman SB, ed: Molecular Biology, Biochemistry and Biophysics, Vol. 25: Advanced Methods in Protein Sequence Determination. New York, NY: Springer Verlag; 1977:55 67.
  6. Katzav A, Solodeev I, Brodsky O, et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum. 2007;56:938-948.
  7. Katzav A, Ben-Ziv T, Chapman J, Blank M, Reichlin M, Shoenfeld Y. Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS-SLE (depression). J Autoimmun. 2008;31:393-398.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Career DevelopmentConditionsEducation & TrainingProfessional TopicsProfilesResearch RheumSjögren’s Disease Tagged with:Immunologyinflammatory myopathypatient careProfileResearchrheumatologistSclerodermaSjogren'sSystemic lupus erythematosus

Related Articles

    In Memoriam: Morris Reichlin, MD

    September 20, 2018

    With sadness we honor the passing of Morris Reichlin, MD. Dr. “Moe” Reichlin enjoyed a distinguished clinical, investigative, rheumatology career that spanned more than five decades. Moe was inquisitive, persistent, humble and inspiring. His achievements were many and diverse. Moe Reichlin received his BA and MD degrees from Washington University in St. Louis, where he…

    The 2020 ARP Merit Awards & ACR Distinguished Fellows

    December 14, 2020

    During ACR Convergence 2020 in early November, the ACR and ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARP Merit Awards and the ACR’s Distinguished Fellows. In addition, we bring you the first ever…

    2013 ACR/ARHP Annual Meeting: Clues to Predictors of Autoimmune Disease Revealed

    February 1, 2014

    New research clarifies signs of rheumatoid arthritis and systemic lupus erythematosus years in advance and could lead to presymptomatic treatment intervention

    Search for Infectious Triggers of Rheumatic Disease Could Yield Options to Block Process

    January 19, 2016

    SAN FRANCISCO—Two hundred years ago, physicians knew nothing about what caused various forms of arthritis. Today, we have more clues about what may trigger rheumatic diseases, but still can’t pinpoint the culprits that set scores of inflammatory conditions in motion. Researchers discussed some of the background and recent findings that point to what immunologists call…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences